Advertisement
Advertisement

CTXR

CTXR logo

Citius Pharmaceuticals Inc. Common

0.75
USD
Sponsored
+0.04
+5.90%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

0.75

-0.01
-0.66%

CTXR Earnings Reports

Positive Surprise Ratio

CTXR beat 9 of 27 last estimates.

33%

Next Report

In 4 Days
Date of Next Report
Feb 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.52M
/
-$0.01
Implied change from Q4 25 (Revenue/ EPS)
--
/
-98.61%
Implied change from Q1 25 (Revenue/ EPS)
--
/
-99.23%

Citius Pharmaceuticals Inc. Common earnings per share and revenue

On Dec 26, 2025, CTXR reported earnings of -0.72 USD per share (EPS) for Q4 25, missing the estimate of -0.49 USD, resulting in a -45.04% surprise. Revenue reached --, compared to an expected 5.87 million, with a -100.00% difference. The market reacted with a -1.69% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 3.52 million USD, implying an decrease of -98.61% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q4 2025, Citius Pharmaceuticals Inc. Common reported EPS of -$0.72, missing estimates by -45.04%, and revenue of $0.00, -100% below expectations.
The stock price moved down -1.69%, changed from $0.84 before the earnings release to $0.83 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 3 analysts, Citius Pharmaceuticals Inc. Common is expected to report EPS of -$0.01 and revenue of $3.52M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement